Employers haven’t a clue how their drug benefits are managed
KFF Health News, 10/9/24
What would a CVS Health breakup mean for stakeholders?
TechTarget, 10/9/24
Pharmacists Fight Back Act
PBM Reform Podcast, 10/8/24
An Overland Park pharmacist quit the drug insurance game. He says it could save you money
Beacon Missouri, 9/25/24
The FTC vs PBM slugfest continues as the government sues the middlemen over insulin rebates
Cost Curve, 9/24/24
Monopoly round-up: Lina Khan, pharma middlemen and "tasty rebates"
BIG by Matt Stoller, 9/22/24
PBMs — The middlemen shaping treatments and costs
Clinical Care Solutions, 8/19/24
To lower prescription drug costs, states head to the courthouse
Stateline, 8/15/24
Antonio Ciaccia presentation to Texas Pharmaceutical Initiative
Texas Health and Human Services, 8/8/24
Harrow doubles price of essential eye medicine Natacyn after acquisition from Eyevance
Capitol Forum, 8/1/24
FTC Report: "Middlemen" are the reason drug prices go up
Columbus Morning News WTVN-AM, 7/29/24
Congress: PBMs harm pharmacies and patients
Business of Pharmacy Podcast, 7/29/24
Unmasking PBMs: Antonio Ciaccia exposes the hidden power players in healthcare
RealPharma Podcast, 7/29/24
Drug middlemen say Pharma sets prices. Then why do middlemen have hundreds for the same drug?
Ohio Capital Journal, 7/26/24
The Role of Pharmacy Benefit Managers in Prescription Drug Markets
U.S. House of Representatives Committee on Oversight and Accountability, 7/23/24
A 46brooklyn report makes clear that PBM pricing in Medicare is a Gordian Knot
Cost Curve, 7/23/24
Express Scripts overcharged postal workers by $45 million, audit says
STAT News, 7/22/24
Inside the Mafia of Pharma Pricing
BIG by Matt Stoller, 7/15/24
FTC report finds PBMs profit at the expense of patients and independent pharmacies
STAT News, 7/9/24
Pharmacy benefit managers: The powerful middlemen inflating drug costs and squeezing Main Street pharmacies
Federal Trade Commission, 7/9/24
Express Scripts is gouging Medicare and seniors on generic HIV prevention drug
Capitol Forum, 6/25/24
PBMs must come clean
Business of Pharmacy Podcast, 6/10/24
Pharmacy benefit managers: the American drug cartel
UNFTR, 6/8/24
Ohioans grapple with medication access as pharmacies shutter
WYSO Dayton, 6/3/24
Why NADAC is a "Ray of Sunshine," with AJ Loiacono and Antonio Ciaccia
The Astonishing Healthcare Podcast, 5/31/24
Pharmacy Benefit Managers and their impact on the pharmaceutical market
Spectrum News Ohio, 5/22/24
Greed of PBMs needs to be reined in at state and federal level
Commonwealth Beacon, 4/30/24
Understanding 340B programs: An interview with Antonio Ciaccia, CEO, 46brooklyn Research
Prescription for Better Access Podcast, 4/25/24
U.S. probes high generic drug prices
Wall Street Journal, 4/16/24
In the PBM Wars, it’s the consumers’ day in court
American Journal of Managed Care, 4/15/24
Working out the strange math and weird consequences of IRA inflation penalties
Cost Curve News, 4/11/24
Did you say 486%? Why one company thinks such a price hike for its drug is justified
STAT News, 4/10/24
Two reports critique financial dynamics of 340B program
340B Report, 3/19/24
Walgreens in West Dayton to close, residents worry about pharmacy access
WYSO Dayton, 3/18/24
Prescribing PBM Reform: Accelerating Transparency with Bipartisan Action
The Hill, 3/6/24
Drugs like Ozempic and Wegovy could boost the US economy by a trillion dollars in a few years, Goldman Sachs predicts
CNN, 2/27/24
Ozempic, Mounjaro and hundreds of other drugs become even more expensive in 2024
CNN, 2/15/24
We uncovered a bribery scandal driving up drug prices
More Perfect Union, 2/14/24
What do the drug price changes announced in January tell us?
First Report Managed Care, 2/14/24
In Columbus, top Biden official touts lowering drug prices, but hedges on kickbacks
WSYX ABC 6 Columbus, 2/12/24
Merck, J&J and Bristol Myers CEOs face drug-pricing grilling on Capitol Hill, but experts cite deeper problems under the radar
MarketWatch, 2/7/24
Pharma companies raise prices on over 900 drugs amid 'historic' negotiations
USA Today, 2/4/24
Vertex's next challenge for pain pill? Cracking a market dominated by cheap opioids
EndPoints News, 1/30/24
A PBM in Africa flips the industry’s script in a bid to make people healthier
STAT News, 1/25/24
Drug makers just hiked prices for Ozempic and a lot of other drugs
Quartz, 1/19/24
Drugmakers hiking prices for more than 700 medications, including Ozempic and Mounjaro
CBS News, 1/18/24
Drugmakers raise prices of Ozempic, Mounjaro and hundreds of other drugs
Wall Street Journal, 1/18/24
Drug cost trends in 2024 are 'nearly unprecedented,' research finds
Becker’s Hospital Review, 1/17/24
What to know about January's annual drug price hikes
NPR, 1/17/24
Biden FDA approves Florida plan to import drugs from Canada
Bloomberg, 1/5/24
Eli Lilly launches home delivery of obesity drug Zepbound — but warns against its use for cosmetic weight loss
MarketWatch, 1/4/24
500 drugs from over 140 brands are expected to cost more this year
PharmaNewsIntelligence, 1/3/24
On the record: A big pharma company slashes its insulin prices
WCBS Newsradio 880, 1/3/24
Insulin $35 cap price now in effect, lowering costs for many Americans with diabetes
USA Today, 1/3/24
With the new year comes new, higher prescription costs
Marketplace, 1/2/24
Exclusive: Drugmakers set to raise US prices on at least 500 drugs in January
Reuters, 12/29/23
ADHD drug prices rise as Adderall shortage leaves patients scrimping to fill prescriptions
USA Today, 12/21/23
Insulin, PBM lawsuits seen as alternative to pricing legislation
Bloomberg Law, 12/19/23
CVS’s new drug payment plan won’t lower patients’ prices, experts warn
STAT News, 12/5/23
CVS says it will change the way its pharmacies are paid
The New York Times, 12/5/23
Unravelling drug pricing - A conversation with Antonio Ciaccia
The PharmCast, 11/27/23
Weight-loss drugs just got cheaper — and better
Business Insider, 11/11/23
The doctor lowering drug prices for 1 million patients, with help from Mark Cuban, Sam Altman – and Martin Shkreli
MarketWatch, 11/6/23
Pfizer RSV vaccine lags GSK’s as head-to-head competition underway
Reuters, 10/30/23
Blue Shield of California is promising a simpler, cheaper pharmacy benefits model. Can it deliver?
Healthcare Dive, 10/25/23
How to pay for million-dollar cures
Bloomberg, 10/15/23
Mission critical: Reform the mysterious PBM system with Antonio Ciaccia
Pharmacy Podcast Network, 10/14/23
Discounts for weight loss drugs are estimated at more than half, fueling questions about price, PBMs and coverage
Endpoints News, 10/6/23
Few San Franciscans are obese, but many still want Ozempic
The San Francisco Standard, 9/25/23
Save billions or stick with Humira? Drug brokers steer Americans to the costly choice
Los Angeles Times, 9/18/23
Generic drugs should be cheap, but insurers are charging thousands of dollars for them
Wall Street Journal, 9/11/23
Medicare patients paid 4 times as much as their drug plans for certain medicines, study finds
MarketWatch, 9/7/23
Mid-year drug price hikes are back despite Inflation Reduction Act
STAT News, 8/24/23
Bolt's Breslow started a medical research company. Now it's reminiscent of Goop.
Axios, 8/24/23
Blue Shield CA taps Amazon, Mark Cuban, CVS for new PBM model
Modern Healthcare, 8/17/23
Next-gen weight-loss drugs receive tentative embrace by Medicaid
Bloomberg Law, 7/26/23
Navigating supply chain dynamics & pricing disparities of biologics, biosimilars
Xtelligent Healthcare Media, 7/11/23
Governor Murphy signs legislative package to make prescription drugs more affordable for New Jerseyans
Office of the Governor of New Jersey, 7/10/23
For AbbVie’s blockbuster Humira, cheaper competitors pose surprisingly little threat, analysts say
MarketWatch, 6/30/23
Drugmakers warn new law will deter discoveries
Indiana Business Journal, 6/30/23
Expert weighs in on why drug prices continue to climb
KMTV Twin Falls, 6/26/23
Drugmakers restricting 340B pharmacy sales threaten PBMs profits
Modern Healthcare, 6/9/23
How inflation, competition, biosimilars affect prescription drug costs
PharmaNewsIntelligence, 6/7/23
Merck suit poised to send Biden drug price law to Supreme Court
Bloomberg Law, 6/7/23
Merck lawsuit challenging Medicare drug price negotiation signals long battle ahead, experts say
MarketWatch, 6/6/23
Why prescription drug prices in the US are so high
Washington Post, 6/6/23
Even Mark Cuban can’t fix this broken drug system
Wall Street Journal, 6/5/23
Podcast: Rage against the machine: Pharmacy benefit managers
Rxperience Podcast, 6/5/23
Drug label anti-fraud provisions solidified in Medicaid proposal
Bloomberg Law, 5/26/23
Copay accumulator lawsuit aims to reduce costs to patients
Benefits Pro, 5/25/23
Congress took on high drug prices in Medicare. Now Biden wants to take it to Medicaid
STAT News, 5/24/23
Pharmacy benefit manager group decries House hearing agenda
Bloomberg Law, 5/23/23
Here’s how new laws could lower Indiana residents’ health care costs
WFYI Indianapolis, 5/22/23
How DeSantis is trying to lure older voters away from Trump
The New York Times, 5/22/23
FTC orders records from Zinc Health, Ascent Health as PBM probe widens
Modern Healthcare, 5/17/23
Insurers, PBMs restrict access to weight loss drugs as demand soars
Modern Healthcare, 5/16/23
Exclusive drug dealing: Anticompetitive practices in the pharmaceutical supply chain
The Capitol Forum, 5/15/23
Report: “Specialty” drugs are by far the most expensive, but classification seems arbitrary
Ohio Capital Journal, 5/15/23
Drug wholesalers elude Congress scrutiny in pricing debate
Bloomberg Law, 5/5/23
Greater pharmacist role improves pharma supply chain management
PharmaNewsIntelligence, 4/20/23
Mark Cuban ventures into the world of branded drugs
Healthcare Brew, 4/13/23
Express Scripts makes price transparency move amid government scrutiny
Modern Healthcare, 4/13/23
Indiana House passes bill to lower drug costs but some worry it’s too watered down to be effective
WFYI Indianapolis, 4/12/23
Podcast: Spotting anticompetitive conduct in pharma supply chain
Second Request Podcast, 4/4/23
Prescription-drug middlemen face mounting pressure from federal government, states
MarketWatch, 3/31/23
US FDA approves over-the-counter sale of overdose reversal drug Narcan
Reuters, 3/29/23
Drug price-sharing strategy imperiled by Ohio antitrust suit
Bloomberg Law, 3/29/23
Transcript of conference call with 46brooklyn CEO Antonio Ciaccia on spotting anticompetitive practices in the pharmaceutical supply chain
Capitol Forum, 3/22/23
Drugmaker data, price negotiation timeline tee up fight with HHS
Bloomberg Law, 3/20/23
3 major insulin makers have now slashed the price of the life-saving drug. Here's why.
USA Today, 3/16/23
New drugs for cancer, rare disease can now cost more than $20,000 a month
Wall Street Journal, 3/9/23
Eli Lilly’s insulin decision puts others in hot seat
Wall Street Journal, 3/8/23
House inquiry intensifies pressure on PBMs
Modern Healthcare, 3/6/23
Patients caught in drug industry, PBM battle on copay assistance
Bloomberg Law, 3/6/23
Pharmacy benefit managers put in crosshairs of drug price fight
Bloomberg Law, 3/3/23
Ozempic shortages? Some pharmacists are choosing not to stock the drug at all
NBC News, 3/2/23
Eli Lilly to cut insulin prices up to 70% amid federal pressure to lower costs
USA Today, 3/1/23
Analyzing 2023 drug list price increases by pharmaceutical companies
PharmaNewsIntelligence, 2/28/23
How 3 companies came to dominate the PBM market
Healthcare Brew, 2/15/23
Sen. Chuck Grassley will hold a full bipartisan committee hearing this week on one of the main causes of skyrocketing prescription drug prices: Pharmacy Benefit Managers (PBMs)
The Doug Wagner Show, 2/15/23
Mark Cuban and Amazon are shaking up generic drugs
Wall Street Journal, 2/3/23
Drugmakers raise prices on nearly 1,000 medicines but show restraint
Wall Street Journal, 2/2/23
Why drugmakers have raised prices on nearly 1,000 drugs so far this year
USA Today, 1/30/23
Walgreens eyes pharmacy divest
Axios, 1/26/23
Here’s how GOP lawmakers in Indiana hope to address high health care costs
WFYI Indianapolis, 1/19/23
Major purchasers predict expensive new therapies will keep driving drug price hikes
STAT News, 1/17/23
2022 US drug price rises high - but mostly not as high as inflation
The Pharma Letter, 1/17/23
Medicare launches plan to negotiate prices for the costliest drugs. Here's what to know.
USA Today, 1/11/23
Blues plans launch Synergie to cut costs for the priciest drugs
Modern Healthcare, 1/6/23
January’s new drug price increases take off without overcompensating for upcoming inflation-linked rebates
Endpoints News, 1/4/23
Drug makers start 2023 with price hikes
Formulary Watch, 1/4/23
Pfizer, GSK, AbbVie and many more celebrate New Year with price hikes: report
Fierce Pharma, 1/4/23
Pharma companies boost drug prices to start year, but hikes lag inflation
BioPharma Dive, 1/3/23
Pharma companies to hike cost of over 350 drugs in 2023: Analysis
NTD News, 1/2/23
Exclusive: Drugmakers to raise prices on at least 350 drugs in U.S. in January
Reuters, 12/30/22
More Blues agree to pay for prescription digital therapies
Modern Healthcare, 11/14/22
How Ohio's new single pharmacy benefit manager will affect you
Columbus Dispatch, 10/20/22
Vertical integration podcast
Business of Pharmacy Podcast, 10/10/22
Mark Cuban’s drug company teams up with first health insurer
Modern Healthcare, 10/7/22
How will the Inflation Reduction Act impact PBM reform?
PBM Reform Podcast, 10/4/22
Kroger, Express Scripts mired in contract dispute
Modern Healthcare, 10/3/22
Legislators discuss reforming rules for pharmacy benefit managers
Richmond Register, 9/29/22
The multi-billion dollar Rx middlemen: PBMs explained
Patients Rising Podcast, 9/23/22
Why the price of prescription drugs is rising
WPHM-AM Paul Miller Morning Show, 9/20/22
Oregon pharmacy group estimates changes coming from federal price negotiation
Jefferson Public Radio, 9/20/22
With new acquisition, CVS to get bigger and broader, raising concerns
Ohio Capital Journal, 9/14/22
The 340B drug pricing program: Challenges and solutions
American Action Forum, 9/12/22
Frustrated pharmacists are opting out of the insurance system, saving some customers hundreds of dollars a month
The Today Show, NBC News, 8/19/22
He hiked the price of a drug 5000%. Was he actually evil?
Newsthink via YouTube, 8/18/22
Ryan Breslow bolts into pharmacy with $7.5M seed
Axios Pro, 8/17/22
Experts: Dems’ drug measures are good for seniors. But there are downsides
Ohio Capital Journal, 8/12/22
Drug price bill shifts dollars from cancer meds, analysts warn
Bloomberg Law, 8/10/22
Haggling with Pharma: Medicare drug price negotiations explained
Bloomberg Law, 8/9/22
US government poised for long-awaited powers on drug pricing
Bloomberg, 8/5/22
Civica Rx begins selling its first outpatient generic drug as it tries to overhaul the pharmaceutical supply chain
STAT News, 8/3/22
'Shop around' Rising cost of prescribed medications hits Georgians
WMAZ Macon, 8/2/22
46brooklyn CEO Antonio Ciaccia talks rising prescription drug prices on Michigan’s Big Show
Michigan’s Big Show starring Michael Patrick Shiels, 8/2/22
Drug price hikes effect Richmond Hill Pharmacy and others nationwide
WJCL Savannah, 8/1/22
Why prescription drug prices in the US are so high
Bloomberg, 7/19/22
UnitedHealthcare to set $0 copay for insulin, other medications
Modern Healthcare, 7/15/22
Manchin plays spoiler again, but drug pricing reforms remain on the table
EndPoints News, 7/15/22
Drug pricing plan faces industry gripes as Senate reconvenes
Bloomberg Law, 7/11/22
Chronically ill patients want voice in FTC pharmacy agent probe
Bloomberg Law, 7/8/22
Gun legislation provision puts drug supply chain profits over patients
The Hill, 6/28/22
The story behind prescription drug prices in Nevada
KDWN Talking Solutions Public Affairs Show, 6/27/22
CVS Caremark returns Eliquis to formulary after outcry
Modern Healthcare, 6/22/22
Feds to probe drug rebates
Ohio Capital Journal, 6/20/22
Fears ease on new pharmacy deserts in Ohio: 'The state is going to save a lot of money'
Columbus Dispatch, 6/20/22
Antonio Ciaccia: Fix to health insurance isn't high drug costs (Opinion)
Charleston Gazette-Mail, 6/17/22
A ‘veritable playground’: CVS whistleblower details how patients were charged higher drug prices
STAT News, 6/16/22
Medicaid director: Despite fears, Ohio's poor and disabled won't be harmed by drug revamp
Columbus Dispatch, 6/15/22
Federal PBM probe culminates decades of M&A
Modern Healthcare, 6/14/22
Undercover: Britain's biggest GP chain
BBC Panorama, 6/13/22
FTC agrees to 'shine a light' on how drug middlemen impact your prescription prices
Columbus Dispatch, 6/8/22
Bipartisan legislation can finally lower prescription drug prices
Inside Sources, 6/7/22
A no good, very bad week for the FDA
STAT News, 5/25/22
The Check Up: Antonio Ciaccia of 3 Axis Advisors
Modern Healthcare, 5/16/22
Unlock the full potential of pharmacists with Antonio Ciaccia
Talk to Your Pharmacist Podcast, 5/1/22
Tom Price and David Balat: $35 insulin legislation is style over substance
Breitbart, 4/27/22
Usual and customary? Rite Aid ordered to pay Humana $123 million for inflating pharmacy claims
STAT News, 4/26/22
Former OptumRx CEO jumps back into pharmacy with Waltz Health
Axios Pro, 4/26/22
California investigating Centene over alleged Medicaid fraud
Modern Healthcare, 4/25/22
Cincinnati Issues with Lincoln Ware
Star64 Cincinnati, 4/17/22
8 in 10 say prescription drug prices "unreasonable"
Public News Service, 4/11/22
Specialty pharmacy startup nets $25M
Axios, 3/14/22
Venrock leads pharmacy startup's $20m refill
Axios, 3/10/22
Pharmacy agent study would show role in drug price ‘dysfunction’
Bloomberg Law, 3/7/22
If Medicare Part D redesign ever happens, it could lead to lower prescription drug prices
Forbes, 3/2/22
Podcast: Generic competition for dimethyl fumarate
Neurology Podcast, 3/2/22
Vertical integration secures PBMs as ‘arsonists and firefighters’ of drug prices
Healio, 2/22/22
When the $10K brand name drug is more affordable than its $450 generic: How PBMs control the system
Endpoints News, 2/18/22
FTC plots a look into the competitive impact of PBMs on drug prices, pharmacies
Endpoints News, 2/11/22
CVS adds more vital drugs to formulary exclusions
Modern Healthcare, 2/7/22
As insulin prices soar, some patients ration their doses: ‘You try to make do’
Ohio Capital Journal, 2/7/22
Generic drug for CHB stayed expensive despite competition, says analysis
FDA News, 1/28/22
Podcast: 46Brooklyn's Antonio Ciaccia on Jan. 1 price hikes
Redeeming Value Podcast, 1/25/22
Proposed drug supply chain rule is mere table ante for broader 'rebate' reform
The Hill, 1/25/22
Trends in pricing and out-of-pocket spending on entecavir among commercially insured patients, 2014-2018
JAMA Network Open, 1/21/22
This is why prescription drugs cost so much
KSL News Radio, 1/14/22
Here’s one way Washington is moving to slash seniors’ prescription-drug costs
MarketWatch, 1/12/22
Launch prices rising faster than prices for existing drugs
Inside Health Policy, 1/7/22
Proposed change in federal rules could generate 'real savings' for Medicare recipients
Columbus Dispatch, 1/7/22
Happy new year? Drug prices rising as 2022 begins
MarketWatch, 1/5/22
After years of decline, drugmakers' price hikes may have bottomed out
BioPharma Dive, 1/5/22
The big-ticket drugs that have higher prices in 2022
Axios, 1/4/22
Multiple blockbusters from Gilead, Pfizer, Vertex see (list) price hikes to start 2022
EndPoints News, 1/4/22
460 Drug Prices Already Increased in 2022
Bio Space, 1/4/22
Drug makers ring in the new year with 5% price hikes on hundreds of medicines
STAT News, 1/3/22
Ohio launches probe of PBM practice that critics say gouges patients and taxpayers
Columbus Dispatch, 12/29/21
Insulin prices stay high as rebates drive up costs for diabetics
USA Today, 12/13/21
‘Grandma and grandpa aren’t going to figure this one out.’ Prescription-drug savings vanish in the Medicare shuffle
MarketWatch, 12/10/21
Insurers slam critical drug-pricing research but can’t vouch for their own
Ohio Capital Journal, 12/9/21
Centene hands over millions to another state as Medicaid PBM oversight rises
Modern Healthcare, 12/7/21
For one drug at least, biggest insurers force Medicare patients to buy the most expensive
Ohio Capital Journal, 12/7/21
Podcast: The drug pricing middlemen driving up drug costs
National Consumers League, 12/1/21
Congressional group takes up PBMs, strikes a partisan tone
Ohio Capital Journal, 11/26/21
Making sense of the PBM scam: A conversation with Antonio Ciaccia
Conscious Pharmacist Podcast, 11/25/21
Powerful drug-industry middlemen have quietly launched businesses to get better deals from drugmakers. It could drive up costs for patients.
Business Insider, 11/22/21
Capitol Insider: 'The PBM robbed her of hope'; pharmacy benefit managers ripped in hearing
Columbus Dispatch, 11/19/21
Future of Healthcare Summit - Tackling Costs & Pathways to Care
The Hill, 11/17/21
PBM Forum wrap up: Greater transparency, further congressional review needed to lower drug prices
House Committee on Oversight and Reform Republicans, 11/17/21
House committee chair presses state pharmacy board on ivermectin
Ohio Capital Journal, 11/12/21
State of Health episode 22: Pharmacy benefit managers (PBMs) and their hidden role in drug pricing
The State of Health Podcast with Gunnar Esiason, 11/10/21
PBM clawbacks sidestep state bans on spread pricing
Modern Healthcare, 10/29/21
Merck's Keytruda close to becoming top-selling drug in the world
Becker’s Hospital Review, 10/29/21
A group backed by huge companies like Walmart and Boeing is fighting back against the drug-industry middlemen in trouble for overcharging customers
Business Insider, 10/28/21
46brooklyn CEO / 3 Axis Advisors president Antonio Ciaccia presentation on drug pricing distortions to the Ohio Joint Medicaid Oversight Committee
The Ohio Channel, 10/27/21
A disrupting force, or ‘just another mail order pharmacy’? How Amazon Pharmacy stacks up a year after launching
STAT News, 10/21/21
What are pharmacy benefit managers and what role do they play in the price of your prescriptions?
Cincinnati Public Radio, 10/19/21
Dispensing doctors: Should physicians sell drugs to patients?
Undark, 10/11/21
Startup PBMs' ties to legacy competitors spark transparency questions
Modern Healthcare, 10/5/21
Study: Without more transparency laws pharmacy benefit managers can continue to drive prescriptions prices up
KMVT 11, 9/15/21
U.S. government to tackle Medicare drug payments to try to cut costs
Reuters, 9/9/21
Bipartisan senators introduce bill to price cap insulin cost share
Ohio Capital Journal, 9/2/21
Pharmacy benefit managers are feeling a push from states to ‘turn the lights on’ to their business practices
Morning Consult, 8/26/21
Podcast: Uncovering $244 million in PBM spread pricing with Antonio Ciaccia
Independent Pharmacy Alliance Podcast, 8/25/21
Meet the 30 young leaders forging a new future for the healthcare industry in 2021
Business Insider, 8/16/21
Uncovering, understanding the structure that underlies US drug pricing distortions
Pharmacy Times, 8/12/21
‘Outrageously expensive’: Biden calls on Congress to lower prescription drug costs
FOX KTVU, 8/12/21
Drug price inflation stalls as spending for certain products rises
Modern Healthcare, 7/30/21
More brand-name drug prices hiked this year than in all of 2020, study finds
Becker’s Hospital Review, 7/28/21
Prescription drug 'sticker prices' may rise in 2021 after years of decline
Washington Examiner, 7/21/21
Cigna members who pay to use biosimilars draw ire from vendors
Modern Healthcare, 7/21/21
Opinion: Costly PBM drug pricing tactics impede the pursuit of health equity
Erie Times-News, 7/20/21
Health systems' rare rejection of Alzheimer's drug sparks questions about FDA approvals
Modern Healthcare, 7/20/21
Generic drug price tags: Too high. And too low. Competition can help create an in-between.
Managed Healthcare Executive, 7/13/21
High costs, high deductibles inspire cash pay
Modern Healthcare, 6/25/21
A lawsuit against the largest provider of government health insurance gives a rare glimpse into how pharmacy benefit managers can make money
Business Insider, 6/16/21
Even with 11 generic competitors, prices for one drug remain a lot higher than they need to be
Ohio Capital Journal, 5/28/21
Drug discount programs' prices often aren't close to cost, analysis finds
Becker’s Hospital Review, 5/26/21
Why drug-discount programs aren't always a good deal
Axios, 5/26/21
As a bill restricting drug formulary changes advances in New York, opponents warn of increased costs
Crain’s New York Business, 5/14/21
Alvotech files lawsuit challenging AbbVie’s Humira patent thicket
pharmaphorum, 5/12/21
Podcast: Leadership strategy implications for the changing pharmacy landscape
Leadership Lessons in Health-System Pharmacy podcast, 5/11/21
AbbVie CEO is on deck as antitrust hearings heat up
AJMC Center for Biosimilars, 5/3/21
Podcast: Drug Prices in Ohio: What is to Be Done?
Prognosis Ohio, 4/22/21
Holistic drug price reform deemed vital to avert cost inequities
Bloomberg Law, 4/16/21
Too little, too late
The Bethlehem Press, 4/13/21
Podcast: Patients ripped off on medications
Disruptive Front Podcast, 4/12/21
Ohio attorney general sues a health plan over its PBM contracts and Medicaid costs
STAT News, 3/11/21
List prices on prescriptions rising, what to do if it impacts you
WKEF/WRGT Dayton, 2/23/21
While attention is on COVID, drug makers are raising prescription prices
NewsRadio 740 KTRH Houston, 2/11/21
Pharmacy benefit managers take heavy criticism from a new source: local officials
STAT News, 2/1/21
Interview: Rising prescription drug prices with Antonio Ciaccia
55KRC Cincinnati, 1/27/21
US sets new record for brand-name prescription drug price increases
Columbus Dispatch, 1/24/21
The new year and COVID-19 could impact your prescription drug prices
WKEF/WRGT Dayton, 1/20/21
With America's attention on COVID-19, drugmakers are raising US prices across the board
Columbus Dispatch, 1/14/21
Mark Cuban wades into the generic drug shark tank with a new company
STAT News, 1/13/21
State-regulated PBM expected to save Ohio up to $200M
Inside Health Policy, 1/13/21
Drugmakers raise prices on more than 750 drugs in the U.S.
Investopedia, 1/11/21
Pharma firms ring in 2021 by hiking prices for hundreds of drugs
New York Post, 1/5/21
Big drugmakers just raised their prices on 500 prescription drugs
CBS News, 1/5/21
Drugmakers kick off 2021 with 500 U.S. price hikes
Reuters, 1/4/21
Pharma rings in the new year with 5% price hikes on hundreds of medicines
STAT News, 1/4/21
Specialty generics face a maze of perverse incentives in Medicare Part D
Forbes, 1/4/21
Fact check: Facebook post touting decreasing drug prices under Trump is misleading
USA Today, 12/4/20
Collinsville startup aims to upend the powerful, opaque drug-pricing system
Hartford Business Journal, 11/16/20
Generic drug prices creep back up after months of falling
Inside Health Policy, 10/30/20
Dexamethasone price has increased 137% in recent months
Becker’s Hospital Review, 10/7/20
Podcast: Complete and fundamental payment reform with Antonio Ciaccia
The Business of Pharmacy Podcast, 10/5/20
Podcast: Copaxone and drug pricing
Neurology Podcast, 9/21/20
Vaccine maker got $1 billion from taxpayers. Now it’s boosting drug prices
Los Angeles Times, 9/14/20
Trump assertions of lower drug costs mask truth for many consumers
Roll Call, 9/9/20
Report: Pharma could game favored-nation policy
Inside Health Policy, 9/1/20
Analysis: U.S. pays substantially more than Australia for the same prescription drugs
Arnold Ventures, 9/1/20
Podcast: Exploring the opaque world of drug pricing with Eric Pachman
The Business of Pharmacy Podcast, 8/24/20
46Brooklyn spotlights Part D feature that favor brands over generics
Inside Health Policy, 8/13/20
‘Canary in a coal mine': Expensive brand-name drugs thrive in Medicare Part D despite generic competition, driving up costs
Arnold Ventures, 8/12/20
Generic drug prices ‘tanking,’ despite fears of pandemic price gouging
Inside Health Policy, 7/28/20
Hospitals see shortages of a cheap steroid that one study says helps Covid-19 patients
STAT News, 6/25/20
Dexamethasone is creating cautious optimism
Axios, 6/17/20
COVID-19: Drug shortages amid a pandemic
National Conference of State Legislatures blog, 6/8/20
4 ways PBMs are changing
Managed Healthcare Executive, 6/20
Pricing watchdog says hydroxychloroquine price spike isn’t abnormal
Inside Health Policy, 5/26/20
Generic prices fall significantly in February, despite recent upward trend
Inside Health Policy, 4/28/20
COVID-19 reveals fissures in the nation’s prescription drug supply chain
Arnold Ventures, 4/20/20
Prices were rising on COVID-19 drug prospects before trials began
Inside Health Policy, 4/16/20
States with transparency laws monitor prices of potential COVID-19 drug treatments
National Academy for State Health Policy, 4/7/20
Amid hydroxychloroquine hopes, lupus patients face shortages
Undark, 3/22/20
Pennsylvania hearing on prescription drug costs goes nowhere
Erie Times-News, 2/27/20
Public hearing on prescription drug prices
Pennsylvania House of Representatives Health Committee, 2/25/20
Biosimilars: What will it take to deliver on their promise?
STAT Reports, 1/28/20
Analysis shows wide disparity in pharmacy benefit manager pricing
Scranton Times-Tribune, 1/27/20
How rebates cut — and distort — government drug spending
Axios, 1/22/20
Maryland bans spread pricing following report on the practice’s cost
Inside Health Policy, 1/17/20
'This is just a rip off': Expensive insulin contributed to man's death at age 39
Indianapolis Star, 12/29/19
AWP: Three little letters that could affect your wallet and health
Columbus Dispatch, 12/22/19
Capitol Insider: Trump administration used skewed data to proclaim prescription drug price drop
Columbus Dispatch, 11/10/19
It’s transparent: States identify costly drugs, including drugs with price hikes deemed unsupported by evidence
National Academy for State Health Policy, 11/4/19
Pharmaceutical industry stakeholders call for reform, investment in generic drugs
Washington Times, 10/16/19
New drugs are launching with ever-higher prices
Axios, 10/16/19
Editorial: PBM whack-a-mole: Fixing one problem doesn’t mean true reform
Columbus Dispatch, 9/17/19
Specialty drug prices leap in Ohio, lifting bottom line for pharmacy benefit managers
Columbus Dispatch, 9/8/19
Insurers, pharmacy benefit managers driving up drug costs
CommonWealth Magazine, 8/22/19
When drug prices jump, so does Trump — if he sees it on the news
Bloomberg Law, 8/13/19
Generic drugs 'wildly overpriced' in Medicare, study finds
Becker’s Hospital Review, 7/15/19
The Wild West of generic drugs in Medicare
Axios, 7/15/19
Generics prices aren't falling like they used to
Axios, 7/2/19
Two more big states take aim at PBM pricing practices, which one lawmaker calls ‘the wild west’
STAT News, 6/5/19
PolitiTalk Podcast featuring Antonio Ciaccia
PolitiTalk Podcast, 5/16/19
As Trump’s drug plan turns one, prices drop but future unclear
Bloomberg Law, 5/13/19
Bellbrook man’s data crunching driving big pharmacy change
Dayton Daily News, 5/13/19
Medicaid managed care programs’ contracts for generic drugs are inefficient
Health Affairs, 5/1/19
Ohio Medicaid officials to crack down on PBM specialty drug practice
Columbus Dispatch, 4/30/19
Questions raised on how pharmacy benefit managers profit from specialty drugs
Columbus Dispatch, 4/24/19
The questionable ties between pharmacy benefit managers and specialty pharmacies
Axios, 4/24/19
Specialty drugs: The new arena for pharmacy benefit manager profits?
Columbus Dispatch, 4/23/19
Ohio AG calls for ‘immediate legislative action’ against PBMs
Inside Health Policy, 4/22/19
Andy Beshear investigating suspected state Medicaid drug price gouging
Louisville Courier Journal, 3/22/19
Webinar: Tools you can use to dig into national prescription drug pricing
The Council of Insurance Agents & Brokers, 3/21/19
Overcharges on generic Prilosec give Ohio taxpayers heartburn
Columbus Dispatch, 3/10/19
FDA chief's resignation greeted mostly by surprise, praise
MedPage Today, 3/6/19
Lilly to introduce generic insulin drug that slashes price 50 percent
Indianapolis Star, 3/4/19
How lawmakers could pressure top pharma execs in Senate hearing
BioPharma Dive, 2/25/19
Sanofi handed payers nearly $12B in drug rebates last year
BioPharma Dive, 2/21/19
Amazon’s latest target is pharmacy disruption
Indianapolis Business Journal, 2/21/19
Egalet's 70% price increase shows the buy-and-hike strategy is alive and well
FiercePharma, 2/15/19
Drug company raises price of pain reliever by 70%
Axios, 2/14/19
A costly oversight: the ongoing impact of the Valsartan recall
Pharma Technology Focus, 2/1/19
Pfizer, Novartis, Amgen add to 2019 drug price hikes
BioPharma Dive, 1/25/19
The Midterm’s Biggest Winners: Medicaid And Rural America
Health Affairs, 1/25/19
Generic drug prices drop: 4 notes
Becker’s Hospital Review, 1/25/19
Pharmacy benefit managers marked up generic drugs for NY Medicaid, but where’d the money go?
Pharmalot via STAT News, 1/24/19
Brand-name drug price hikes are fewer, but still above inflation
Becker’s Hospital Review, 1/22/19
Drug makers still raising prices, but seeking fewer hikes
Axios, 1/22/19
Soaring prescription drug prices 'one of the hottest political issues in 2019'
Indianapolis Star, 1/17/19
Prescription drug pricing strategy: Where is the money going?
Boston 25 News, 1/14/19
Prescription look-up tool helps you get closer to actual cost of drugs
Columbus Dispatch, 1/13/19
This bottle of pills costs $20 in one state and $130 in another
Bloomberg, 1/4/19
Pennsylvania auditor recommends new laws to crack down on PBM contracts for Medicaid
Pharmalot via STAT News, 12/11/18
The drug pricing maze
Axios, 11/17/18
Are you paying too much for prescriptions? This tool will help you find out
Columbus Dispatch, 10/29/18
Kaiser Family Foundation annual survey: Medicaid signups flat, spending higher on prescription drugs and addiction care
USA Today, 10/25/18
Prescription Drug Price Look Up
Columbus Dispatch, 10/24/18
Cost of blood pressure drug surges in U.S. after recall
Reuters, 10/16/18
Side Affects podcast: 46brooklyn
Side Affects with McGohan Brabender, 10/1/18
Generic drug prices ⬇️
Axios, 9/21/18
Trying to bring transparency and accountability to prescription drug prices to help lower costs for patients
The Capitolist, 9/20/18
John Arnold: Are pharmacy benefit managers the good guys or bad guys of drug pricing?
STAT News, 8/27/18
Ohio Medicaid drug audit calls for transparency, highlights pharmacy closures
Columbus Dispatch, 8/16/18
Ohio Medicaid cancels contracts with two big PBMs over ‘spread’ pricing
Pharmalot via STAT News, 8/14/18
States question costs of middlemen that manage Medicaid drug benefits
NPR, 8/8/18
Pharmalittle: Curious to know what a pharmacy benefit manager charges state Medicaid programs for drugs and what those same medicines cost pharmacies?
Pharmalot via STAT News, 8/7/18
New site compares Medicaid drug prices across states and overall drug price trends
Connecticut Health Policy Project, 8/2/18
The data showing drug pricing games
Axios, 8/1/18
To learn more about our initial road to seeking drug price transparency, we recommend reading up on the drug pricing controversies in Ohio, where 46brooklyn’s data work sparked a massive investigation into hidden prescription drug mark-ups. For a near-complete rundown on what unfolded in Ohio, check out the award-winning Side Effects series from the Columbus Dispatch. Thanks to Darrel Rowland, Marty Schladen, Cathy Candisky, Lucas Sullivan, and the entire Dispatch team for their tireless work to peel back the drug pricing onion.
Please support local journalism.